Pharmasum’s pipeline currently focuses on niche areas of neurology with high unmet medical need, using our knowledge of protein kinases to design potent, specific, and brain-penetrant inhibitor compounds.

The company’s cutting-edge design and translational medicine engine offer a unique structure-based drug discovery process.